Lian-Yu Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lian-Yu Chen has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
Ramin Mojtabai
Mental Health Department, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
7 shared publicationsEric C. Strain
Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA
5 shared publicationsMing-Chyi Huang
Department of Addiction Sciences, Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan; Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan
5 shared publicationsRosa M. Crum
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, 7th floor, Baltimore, MD 21205
4 shared publications- Silvia Saboia Martins
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
3 shared publications Carla L. Storr
Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA
2 shared publications
Latest Publications
- Open Access
- 25 November 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-13
Trends in the use and nonmedical use of sedatives-hypnotics in the population aged 12 to 64 years in Taiwan: a comparative analysis of the national surveys in 2014 and 2018
Background: Many countries, including Taiwan, have tightened regulations on prescribing sedatives-hypnotics over the concern of their associated adverse health effects. However, it remains seldom investigated whether different age-sex strata have differential trends in national surveys over time for either the use or nonmedical use (NMU) of sedatives-hypnotics. Comparing Taiwan’s two national surveys in 2014 and 2018, we aimed to examine (1) the population’s trends for the prevalence of past-year use and NMU of sedatives-hypnotics overall and in age-sex strata; (2) trends for sociodemographic subgroups for those age-sex strata with significant changes in past-year use and NMU of sedatives-hypnotics over time; and (3) trends for sources of and motives for NMU of sedatives-hypnotics. Methods: The national survey enrolled 17,837 participants in 2014 (response rate = 62.2%) and 18,626 participants in 2018 (response rate = 64.6%) of citizens aged 12–64 years. Each participant anonymously completed a computer-assisted self-interview. The questionnaire consisted of sociodemographic variables and the use of various psychoactive substances and sedative-hypnotics, among others. NMU of sedative-hypnotics was defined as using the drug without a prescription, or more frequently, or in larger doses than prescribed. To compare the prevalence between the two waves, we conducted multivariable logistic regression analysis and the difference-in-differences in prevalence was examined with an interaction term between survey year and sex. Results: We found decreasing trends in young adult (18–39 years old) males for both past-year use (3.07–2.29%) and NMU (0.84–0.18%), but increasing trends in adolescents (0.42–0.80%) and young adult females (2.91–3.81%) for past-year use and in adolescents (0.16–0.39%) and middle-aged adult (40–64 years old) females (0.73–1.14%) for past-year NMU of sedatives-hypnotics. Among the young and middle-aged adult females, the increasing trends for past-year use and NMU, respectively, were found to occur mainly in certain sociodemographic subgroups, with alcohol users being the overlapping subgroup. Conclusions: The differential trends over time of past-year use or NMU of sedatives-hypnotics in different age-sex strata in the population have policy implications to curtail the increasing trend over time.
- 25 November 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-13
Open AccessTrends in the use and nonmedical use of sedatives-hypnotics in the population aged 12 to 64 years in Taiwan: a comparative analysis of the national surveys in 2014 and 2018
Background: Many countries, including Taiwan, have tightened regulations on prescribing sedatives-hypnotics over the concern of their associated adverse health effects. However, it remains seldom investigated whether different age-sex strata have differential trends in national surveys over time for either the use or nonmedical use (NMU) of sedatives-hypnotics. Comparing Taiwan’s two national surveys in 2014 and 2018, we aimed to examine (1) the population’s trends for the prevalence of past-year use and NMU of sedatives-hypnotics overall and in age-sex strata; (2) trends for sociodemographic subgroups for those age-sex strata with significant changes in past-year use and NMU of sedatives-hypnotics over time; and (3) trends for sources of and motives for NMU of sedatives-hypnotics. Methods: The national survey enrolled 17,837 participants in 2014 (response rate = 62.2%) and 18,626 participants in 2018 (response rate = 64.6%) of citizens aged 12–64 years. Each participant anonymously completed a computer-assisted self-interview. The questionnaire consisted of sociodemographic variables and the use of various psychoactive substances and sedative-hypnotics, among others. NMU of sedative-hypnotics was defined as using the drug without a prescription, or more frequently, or in larger doses than prescribed. To compare the prevalence between the two waves, we conducted multivariable logistic regression analysis and the difference-in-differences in prevalence was examined with an interaction term between survey year and sex. Results: We found decreasing trends in young adult (18–39 years old) males for both past-year use (3.07–2.29%) and NMU (0.84–0.18%), but increasing trends in adolescents (0.42–0.80%) and young adult females (2.91–3.81%) for past-year use and in adolescents (0.16–0.39%) and middle-aged adult (40–64 years old) females (0.73–1.14%) for past-year NMU of sedatives-hypnotics. Among the young and middle-aged adult females, the increasing trends for past-year use and NMU, respectively, were found to occur mainly in certain sociodemographic subgroups, with alcohol users being the overlapping subgroup. Conclusions: The differential trends over time of past-year use or NMU of sedatives-hypnotics in different age-sex strata in the population have policy implications to curtail the increasing trend over time.
- Open Access
- 5 May 2024
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 34 (5) , 218-227
The Use of Premixed Drugs in Commodity Packets in the Population: Prevalence and Correlates Revealed by the 2018 National Survey of Substance Use in Taiwan
Background: Administering premixed drugs in commodity packets was first reported in Asia in 2015, but there continues to be a dearth of related population-based data. This study aimed at examining (1) the prevalence of drug packet use in the population and (2) the sociodemographic profiles, particularly gender distribution, of drug packet users.Methods: Data were derived from a survey of 18,626 Taiwanese civilians, aged 12-64 years, using stratified, multi-stage, random sampling in 2018. Participants anonymously completed a computer-assisted self-interview on tablet computers which covered the use and problematic use of illicit drugs/inhalants, prescription drugs and other psychoactive substances, among others.Results: Approximately 1.46% of respondents had a lifetime use of illicit drugs, with drugs in commodity packets (0.18%) being ranked the fifth-most commonly used illicit drugs, higher than nitrous oxide (0.14%) and heroin (0.09%). Ten formats of drug packets were endorsed by users. Approximately 81.6% of persons with drug packet use had a lifetime use of other illicit drugs. The correlates of the use of drugs in commodity packets were similar to those of the exclusive use of other drugs except that there was a lack of gender differences in the use of drugs in commodity packets but not in the exclusive use of other drugs.Conclusion: Drugs in commodity packets have become a common way of administering illicit drugs in the population in Taiwan, and there were no gender differences among users. Our findings have implications for more efficient drug testing and culturally appropriate intervention for drug packet use.
- 5 May 2024
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 34 (5) , 218-227
Open AccessThe Use of Premixed Drugs in Commodity Packets in the Population: Prevalence and Correlates Revealed by the 2018 National Survey of Substance Use in Taiwan
Background: Administering premixed drugs in commodity packets was first reported in Asia in 2015, but there continues to be a dearth of related population-based data. This study aimed at examining (1) the prevalence of drug packet use in the population and (2) the sociodemographic profiles, particularly gender distribution, of drug packet users.Methods: Data were derived from a survey of 18,626 Taiwanese civilians, aged 12-64 years, using stratified, multi-stage, random sampling in 2018. Participants anonymously completed a computer-assisted self-interview on tablet computers which covered the use and problematic use of illicit drugs/inhalants, prescription drugs and other psychoactive substances, among others.Results: Approximately 1.46% of respondents had a lifetime use of illicit drugs, with drugs in commodity packets (0.18%) being ranked the fifth-most commonly used illicit drugs, higher than nitrous oxide (0.14%) and heroin (0.09%). Ten formats of drug packets were endorsed by users. Approximately 81.6% of persons with drug packet use had a lifetime use of other illicit drugs. The correlates of the use of drugs in commodity packets were similar to those of the exclusive use of other drugs except that there was a lack of gender differences in the use of drugs in commodity packets but not in the exclusive use of other drugs.Conclusion: Drugs in commodity packets have become a common way of administering illicit drugs in the population in Taiwan, and there were no gender differences among users. Our findings have implications for more efficient drug testing and culturally appropriate intervention for drug packet use.
- Open Access
- 13 September 2022
- Published by Springer Nature in Research Square
Clinical profiles of first-time drug offenders in Taipei City: Comparison of methamphetamine, MDMA, and marijuana users
Background: Little is known regarding the clinical profiles of first-time drug offenders who received addiction treatment under deferred prosecution in Taiwan. Method: We recruited participants who received addiction treatment under deferred prosecution for methamphetamine (METH), MDMA, and marijuana (MJ) use from 2017 Jan to 2019 Dec. We used contingency analysis and multivariate logistic regression to compare their sociodemographic characteristics, psychiatric and physical comorbidities, and factors associated with treatment dropouts. Results: Of the 1,216 patients, 87.4 % were male and 12.6% female. 77.4% were METH users, with 11.4% MDMA and 11.2% MJ. Compared to the METH group, the MDMA group was more likely to have concurrent use of alcohol, ketamine, and new psychoactive substances, while the MJ group was more likely to have alcohol use only. Both the MDMA and MJ groups were less likely to have substance-induced psychotic disorder (aOR=0.28 [0.09, 0.93], pConclusions: Our study demonstrated distinct clinical profiles of different drug types among first-time drug offenders. Such findings could offer valuable implications for a more tailored intervention program designed for illicit drug users in a legal system.
- 13 September 2022
- Published by Springer Nature in Research Square
Open AccessClinical profiles of first-time drug offenders in Taipei City: Comparison of methamphetamine, MDMA, and marijuana users
Background: Little is known regarding the clinical profiles of first-time drug offenders who received addiction treatment under deferred prosecution in Taiwan. Method: We recruited participants who received addiction treatment under deferred prosecution for methamphetamine (METH), MDMA, and marijuana (MJ) use from 2017 Jan to 2019 Dec. We used contingency analysis and multivariate logistic regression to compare their sociodemographic characteristics, psychiatric and physical comorbidities, and factors associated with treatment dropouts. Results: Of the 1,216 patients, 87.4 % were male and 12.6% female. 77.4% were METH users, with 11.4% MDMA and 11.2% MJ. Compared to the METH group, the MDMA group was more likely to have concurrent use of alcohol, ketamine, and new psychoactive substances, while the MJ group was more likely to have alcohol use only. Both the MDMA and MJ groups were less likely to have substance-induced psychotic disorder (aOR=0.28 [0.09, 0.93], pConclusions: Our study demonstrated distinct clinical profiles of different drug types among first-time drug offenders. Such findings could offer valuable implications for a more tailored intervention program designed for illicit drug users in a legal system.
- Open Access
- 26 April 2022
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 121 (11) , 2257-2264
Survey of substance use among adolescent drug offenders referred from juvenile courts in Taiwan: Clinical epidemiology of single versus multiple illicit substance use
- 26 April 2022
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 121 (11) , 2257-2264
Open AccessSurvey of substance use among adolescent drug offenders referred from juvenile courts in Taiwan: Clinical epidemiology of single versus multiple illicit substance use
- Open Access
- 29 March 2022
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 121 (9) , 1832-1840
Gender differences in clinical characteristics of emergency department patients involving illicit drugs use with analytical confirmation
- 29 March 2022
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 121 (9) , 1832-1840
Open AccessGender differences in clinical characteristics of emergency department patients involving illicit drugs use with analytical confirmation
- Open Access
- 1 March 2022
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 121 (3) , 725-728
Psychiatric manifestations of paramethoxymethamphetamine users in Taiwan
- 1 March 2022
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 121 (3) , 725-728
Open AccessPsychiatric manifestations of paramethoxymethamphetamine users in Taiwan
- Open Access
- 1 March 2021
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 120 (3) , 1036-1038
Clinical correlates of inpatient adolescent drug users in Taiwan
- 1 March 2021
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 120 (3) , 1036-1038
Open AccessClinical correlates of inpatient adolescent drug users in Taiwan
- 1 May 2020
- Published by Elsevier in Psychiatry Research
- Vol. 287, 112271
Clozapine prescription pattern in patients with schizophrenia in Asia: The REAP survey (2016)
- 1 May 2020
- Published by Elsevier in Psychiatry Research
- Vol. 287, 112271
Clozapine prescription pattern in patients with schizophrenia in Asia: The REAP survey (2016)
- Open Access
- 17 April 2019
- Published by Herald Scholarly Open Access in Journal of Addiction & Addictive Disorders
- Vol. 6 (1) , 1-6
Psychiatric Profiles and Clinical Manifestations of Cathinone Users: Case Series of Analytically Confirmed Cathinone Use in Taiwan
The increasing prevalence of new or Novel Psychoactive Substances (NPS) use has been a global public health issue; however, well-described clinical profiles of NPS users have been lacking, especially in Taiwan. Novel cathinone appear to be one of the most popular emerging NPS in East Asia, with a parallel growth in emergency department visits.
- 17 April 2019
- Published by Herald Scholarly Open Access in Journal of Addiction & Addictive Disorders
- Vol. 6 (1) , 1-6
Open AccessPsychiatric Profiles and Clinical Manifestations of Cathinone Users: Case Series of Analytically Confirmed Cathinone Use in Taiwan
The increasing prevalence of new or Novel Psychoactive Substances (NPS) use has been a global public health issue; however, well-described clinical profiles of NPS users have been lacking, especially in Taiwan. Novel cathinone appear to be one of the most popular emerging NPS in East Asia, with a parallel growth in emergency department visits.